Indegene Digital Summit 2025 Explores AI in Life Sciences

Senior life sciences executives convene at the Indegene Digital Summit 2025 to explore how AI is transforming commercialization. The invite-only event at Philadelphia’s iconic Barnes Foundation features global experts sharing real-world insights and showcases programs delivering measurable impact.

Now in its 7th edition, Indegene Digital Summit is a flagship thought leadership platform for the life sciences industry, facilitating dialogue among senior executives, regulators, and digital innovators. This year’s theme, “From Chaos to Clarity - and Better Decisions”, focused on delivering tangible value beyond the hype of Generative AI (GenAI).

Industry leaders share how they are transforming commercial operations, advancing technology initiatives, and rethinking strategy to drive greater impact. Executives engage in wide-ranging yet practical discussions on data unification across the value chain, agent-augmented workforce, GenAI in commercial operations, evolving pharma regulations, zero-rep commercial models, and the future of customer engagement, among others.

The Vital Awards: Recognizing Leaders Shaping the Future of Life Sciences

At the Summit, the Vital Awards celebrates life sciences professionals at the forefront of scientific and technological convergence - who embody bold thinking, transformative work, and an unwavering pursuit of progress to define the future of healthcare. The awards honor innovation and impact across 4 categories:

·         Patient Impact: Leaders engaging, supporting, and empowering patients through innovative treatments, campaigns, or programs.

·         Community Impact: Leaders contributing knowledge, leadership, and action to benefit underserved groups, healthcare professionals, not-for-profits, academia, and the broader ecosystem.

·         Organizational Impact: Leaders transforming organizations through bold and innovative use of data, technology adoption, and fostering collaboration.

·         Market Impact: Leaders driving measurable market success through innovative launch strategies, go-to-market models, and operational excellence.

All nominations underwent a rigorous evaluation by a distinguished, cross-disciplinary jury comprising senior leaders from industry, academia, policy, media, and analyst domains of the life sciences ecosystem. The jury included:

• Chris Lee, VP-Regulatory Affairs Innovation and Strategic Operations, Gilead Sciences
• Dr. David Shulkin, Ninth Secretary, US Department of Veterans Affairs
• Jameson Fleming, Editor-in-Chief, MM+M
• Jill DeSimone, Former President-US Oncology, Merck
• Navneet Puri, Founder & Board Member, Nevakar
• Dr. Nimita Limaye, VP-Research, Life Sciences, IDC
• Dr. Rajesh Nair, President, Indegene, Inc.
• Reynold Panettieri, Vice Chancellor, Rutgers University, and,
• Tanya Monga, SVP-Global Commercial Strategy and Operations, Gilead Sciences

Their combined expertise and diverse perspectives selected honorees based on innovation, measurable impact, and leadership excellence across the life sciences ecosystem.

Vital Awards 2025 Honorees

• Patient Impact: Sunil Verma, SVP, Global Head, Oncology Franchise, AstraZeneca
• Organizational Impact: Nathan Bowmaker, Head of Global Commercial Operations, AstraZeneca; and Catherine Galvin, VP, Global Marketing Digital & AI Business Transformation, Merck
• Market Impact: Marion Dumas, Global Head of Omnichannel, Sanofi

Speaking on the occasion, Manish Gupta, Chairman and CEO, Indegene, said, “Many congratulations to all the honorees. Your innovation and impact are helping our industry shift growth trajectories and become future-ready, inspiring the broader ecosystem to redefine what’s possible. I also want to thank our eminent jury for recognizing leaders whose breakthroughs continue to push the boundaries.”